Načítá se...
Site-specific fatty acid-conjugation to prolong protein half-life in vivo
Therapeutic proteins are indispensable in treating numerous human diseases. However, therapeutic proteins often suffer short serum half-life. In order to extend the serum half-life, a natural albumin ligand (a fatty acid) has been conjugated to small therapeutic peptides resulting in a prolonged ser...
Uloženo v:
| Vydáno v: | J Control Release |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4437666/ https://ncbi.nlm.nih.gov/pubmed/23735573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2013.05.023 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|